Conclusion
In recent years, descriptive studies of the T cell repertoire have contributed in several ways to our understanding of immunodeficiency disease. In human AIDS, it was shown that, overall, TCR repertoire perturbations of various magnitude were taking place throughout the course of disease in both the CD4+ and CD8+ T cell subsets. Available evidence suggests that the repertoire is remarkably stable within a given individual in absence of serious pathological conditions, even across long periods of time (Ciurli et al., unpublished). The fact that patients with AIDS present with TCR repertoire perturbations, even throughout the so-called clinically silent phase of the disease, testifies to the extent of immune destruction that is taking place covertly within the peripheral lymphoid tissues. Since preferential deletions of CD4+ T cells expressing specific Vβ subsets are not consistently seen, and since no HIV protein has so far fulfilled all the classical characteristics of SAgs, one must argue that there is so far little support for the proposal that HIV encodes a conventional SAg. Preferential replication of HIV-1 in Vβ12+ cells seemed to provide both specificity and functional purpose for such an HIV-encoded SAg. However, it now seems that this superantigenic activity is in fact associated more closely with CMV infection. The fact that HIV uses SAg activity supplied in trans by a co-infecting pathogen is another good example of how lentiviruses and herpesviruses mutually profit from each other's functions to further their individual replicative needs. Whether this Vβ12 reservoir is in fact pathologically relevant still remains to be addressed.
Whereas repertoire studies have failed to reveal the presence of a virally encoded SAg in MAIDS virus infection, they have nevertheless suggested the possibility that indirect, perhaps integration-mediated para-oncogenic events, could be involved in the enhanced expression of endogenousmtv genes, and the observed in vitro Vβ-specific expansions. The importance of indirect SAg expression to the pathogenesis of MAIDS, perhaps in terms of expanding the viral reservoir, is so far unclear.
Finally, TCR repertoire studies have also revealed the existence of high-level Vβ-specific expansions, occurring in some patients during the acute phase of HIV infection. All available evidence suggests that these expansions are part of the early cell-mediated immune response to HIV antigens, and are most probably involved in the clearance of the initial viremic episode. These findings are well supported by studies of SIV infection in rhesus macaques. Idiotypic differences in the Vβ expansion patterns, which so far appear to be correlated with disease prognosis, may reflect the differential ability of an individual's TCR repertoire to recognize various HIV cytotoxic epitopes, and/or the relative restriction in the presentation of these peptides by given HLA haplotypes. In other words, a restricted, high-affinity response could be easily counteracted by the virus: selective mutations in cytotoxic epitopes have been documented that abrogate recognition by circulating cytotoxic T cell clones, and that eventually drift far enough from the initial epitope so as to escape presentation by the original class I allele. At the same time, high-level expansion of a T cell clone bearing a high-affinity receptor in the presence of a high viral load could make these T cell clones susceptible to peripheral deletion via high-dose tolerance and clonal exhaustion mechanisms [87]. Several rounds of such a routine would leave the host functionally defenseless with respect to cell-mediated immunity. Through expanded TCR repertoire analysis, we trust that this phenomenon will be revealed in other acute lymphotropic viral infections such as infectious mononucleosis. This type of acute Vβ-specific expansions of T cells expressing activated cytotoxic activity might be a more generalized mechanism of host antiviral response than has been previously thought.
Similar content being viewed by others
References
Toyonaga B, Yoshikai Y, Vadasz V, Chin B, Mak TW (1985) Organization and sequences of the diversity, joining, and constant region genes of the human T-cell receptor beta chain. Proc Natl Acad Sci USA 82:8624
Toyonaga B, Mak TW (1987) Genes of the T cell antigen receptor in normal and malignant T cells. Annu Rev immunol 5:585
Wilson RK, Lai E, Concannon P, Barth RK, Good LE (1988) Structure, organization and polymorphism of murine and human T cell receptorα andβ gene families. Immunol Rev 101:149
Wei S, Charmley P, Robison MA, Concannon P (1994) The extent of the human germ-line T-cell receptor Vβ gene segment repertoire. Immunogenetics 40:27
Panzara MA, Gussoni E, Steinman L, Oksenberg JR (1991) Analysis of the T cell repertoire using PCR and specific oligonucleotide primers. BioTechniques 12:728
Hall BL, Finn OJ (1992) PCR-based analysis of the T cell receptor Vβ multigene family: experimental parameters affecting its validity. BioTechniques 13:248
Labrecque N, McGrath H, Subramanyam M, Huber BT, Sékaly RP (1993) Human T cells respond to mouse mammary tumor virus-encoded superantigen: Vβ restriction and conserved evolutionary features. J Exp Med 177:1735
Rebai N, Pantaleo G, Demarest JF, Ciurli C, Soudeyns H, Adelsberger JW, Vaccarezza M, Walker RE, Sékaly RP, Fauci AS (1994) Analysis of the T-cell receptorβ-chain variable-region (Vβ) repertoire in monozygotic twins discordant for human immunodeficiency virus: evidence for perturbations of specific Vβ segments in CD4+ T cells of the virus-positive twins. Proc Natl Acad Sci USA 91:1529
Choi Y, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J (1989) Interaction ofStaphlococcus aureus toxin superantigens with human T cells. Proc Natl Acad Sci USA 86:8941
Wang X, Ohmen JD, Uyemura K, Rea TH, Kronenberg M, Modlin RL (1993) Selection of T lymphocytes bearing limited T-cell receptorβ chains in response to a human pathogen. Proc Natl Acad Sci USA 90:188
Akolkar P, Gulwani-Akolkar NB, Pergolizzi R, Bigler RD, Silver J (1993) Influence of HLA genes on T cell receptor V segment frequencies and expression levels in peripheral blood lymphocytes. J Immunol 150:2761
Gulwani-Akolkar B, Posnett DN, Janson CH, Grunwald J, Wigzell H, Akolkar P, Gregersen PK, Silver J (1991) T cell receptor V-segment frequencies in peripheral blood T cells correlate with human leukocyte antigen type. J Exp Med 174:1139
Kozak C, Peters G, Pauley R, Morris V, Michalides R, Dudley J, Green M, Davisson M, Prakash O, Vaidya A (1987) A standardized nomenclature for endogenous mouse mammary tumor viruses. J Virol 61:1651
Jouvin-Marche E, Cazenave PA, Voegtle D, Marche PN (1992) V beta 17 T-cell deletion by endogenous mammary tumor virus in wild-type-derived mouse strain. Proc Natl Acad Sci USA 89:3232
Golovkina UA, Chervonsky A, Dudley JP, Ross SR (1992) Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell 69:637
Held W, Waanders GA, Shakhov AN, Scarpellino L, Ach-Orbea H, MacDonald HR (1993) Superantigeninduced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell 74:529
Lafon M, Lafage M, Martinez-Arends A, Ramirez R, Vuillier F, Charron D, Lotteau V, Scott-Algara D (1992) Evidence for a viral superantigen in humans. Nature 358:507
Hanto DW, Frizzera KJ, Gajl-Peczalska, Simmons RL (1985) Epstein-Barr virus, immunodeficiency and B cell lymphoproliferation. Transplantation 39:461
Fauci AS (1988) The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239:617
Pantaleo G, Graziosi C, Fauci AS (1993) The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 328:327
Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA and Fauci AS (1986) Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233:1089
Gabuzda DH, Ho DD, Monte SM de la, Hissch MS, Rota TR, Sobel RA (1986) Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol 20:289
Pantaleo G, Fauci AS (1995) New concepts in the immunopathogenesis of HIV infection. Ann Rev Immunol 13:487
Clark SJ, Shaw GM (1993) The acute retroviral syndrome and the pathogenesis of HIV-1 infection. Semin Immunol 5:149
Klatzmann D, Barré-Sinoussi F, Nugeyre MT, Dauguet C, Vilmer E, Griscelli C, Brun-Vézinet F, Rouzioux C, Gluckman JC, Chermann J-C, Montagnier L (1984) Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science 225:59
Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R (1986) The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333
Chen ZW, Kou ZC, Lekutis C, Shen L, Zhou D, Halloran M, Li J, Sodroski J, Lee-Parritz D, Letvin NI (1995) T cell receptor Vβ repertoire in an acute infection of Rhesus monkeys with simian immunodeficiency viruses and a chimeric simian-human immunodeficiency virus. J Exp Med 182:21
Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M (1995) Rapide turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123
Garry RF (1989) Potential mechanisms for the cythopathic properties of HIV. AIDS 3:683
Sodroski J, Goh WC, Rosen C, Campbell K, Haseltine WA (1986) Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature 322:470
Siliciano RF, Lawton T, Knall, Karr RW, Berman P, Gregory T, Reinherz EL (1988) Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion. Cell 54:561
Garcia JV, Miller AD (1991) Serine phosphorylation-independent downregulation of cell-surface CD4 bynef. Nature 350:508
Laurent-Crawford AG, Krust B, Muller S (1991) The cytopathic effect of HIV is associated with apoptosis. Virology 185:829
Banda NK, Bernier J, Kurahara DK, Kurie R, Haigwood N, Sékaly RP, Finkel TH (1992) Cross-linking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 176:1099
Groux H, Torpier G, Monte D, Mouton Y, Capron A, Ameisen JC (1992) Activation-induced death by apoptosis in CD4+T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 175:331
Pope M, Betjes MG, Romani N, Hirmand H, Cameron PU, Hoffman L, Gezelter S, Sculer G, Steinman RM (1994) Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 78:389
Janeway C (1991) Mls: makes a little sense. News and views. Nature 349:459
Imberti L, Sottini A, Bettinardi A, Puoti M, Primi D (1991) Selective depletion in HIV infection of T cells that bear specific T cell receptor Vβ sequences. Science 254:860
Dalgleish AG, Wilson S, Gompels M, Ludlam C, Gazzard B, Coates AM, Habeshaw J (1992) T-cell receptor variable gene products and early HIV-1 infection. Lancet 339:824
Soudeyns H, Rebai N, Pantaleo GP, Ciurli C, Boghossian T, Sékaly RP, Fauci A (1993) The T cell receptor Vβ repertoire in HIV-1 infection and disease. Semin Immunol 5:165
Hodara VL, Jeddi-Tehrani M, Grunewald J, Andersson R, Scarlatti G, Esin S, Holmberg V, Libonatti O, Wigzell H (1993) HIV infection leads to differential expression of T-cell receptor Vβ genes in CD4+ and CD8+ T cells. AIDS 7:633
Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS (1993) HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355
Embretson J, Zupanic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, Haase AT (1993) Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359
Soudeyns H, Routy JP, Sékaly RP (1994) Comparative analysis of the T cell receptor V-β repertoire in various lymphoid tissues from HIV-infected patients: evidence for an HIV-associated superantigen. Leukemia 8 [Suppl 1]:S95
Clark SJ, Saag MS, Decker WD, Campbell-Hill S, Roberson JL, Veldkamp PJ, Kappes JC, Hahn BH, Shaw GM (1991) High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med 324:954
Graziosi C, Pantaleo G, Butini L, Demarest JF, Saag MS Shaw GM, Fauci AS (1993) Kinetics of HIV DNA and RNA synthesis during primary HIV-1 infection. Proc Natl Acad Sci USA 90:6505
Pantaleo G, Demarest JF, Soudeyns H, Graziosi C, Denis F, Adelsberger JW, Borrow P, Saag MS, Shaw GM, Sékaly RP, Fauci AS (1994) Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV. Nature 370:463
Silverstri G, Soudeyns H, Lapointe N, Samson J, Denis F, Sékaly RP (1995) T cell receptor specific Vβ-specific expansions in children from HIV-infected mothers. AIDS (in press)
Posnett DN, Kabak S, Hodtsev AS, Goldberg EA, Asch A (1993) T-cell antigen receptor V-β subsets are not preferentially deleted in AIDS. AIDS 7:625
Boyer V, Smith LR, Ferre F, Pezzoli P, Trauger RJ, Jensen FC, Carlo DJ (1993) T cell receptor Vβ repertoire in HIV-infected individuals: lack of evidence for selective Vβ deletion. Clin Exp Immunol 92:437
Nisini R, Aiuti A, Matricardi PM, Fattorossi A, Ferlini C, Biselli R, Mezzaroma I, Pinter E, D'Amelio R (1994) Lack of evidence for a superantigen in lymphocytes from HIV-discordant monozygotic twins. AIDS 8:443
Trono D (1995) HIV accessory proteins: leading roles for the supporting cast. Cell 82:189
Torres BA, Johnson HM (1994) Identification of an HIV-1 Nef peptide that binds to HLA class II antigens. Biochem Biophys Res Commun 200:1059
Laurence J, Hodtsev AS, Posnett DN (1992) Superantigen implicated in dependence of HIV-1 replication in T cells on TCR Vβ expression. Nature 358:255
Dobrescu D, Kabak S, Mehta K, Suh CH, Asch A, Cameron PU, Hodtsev AS, Posnett DN (1995) Human immunodeficiency virus 1 reservoir in CD4+ T cells is restricted to certain Vβ subsets. Proc Natl Acad Sci USA 92:5563
Ignatowicz L, Kappler J, Marrack P (1992) The effects of chronic infection with a superantigenproducing virus. J Exp Med 175:917
McCormack JE, Callahan JE, Kappler J, Marrack PC (1993) Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J Immunol 150:3785
Dadaglio G, Garcia S, Montagnier L, Gougeon M-L (1994) Selective anergy of Vβ8+ T cells in human immunodeficiency virus-infected individuals. J Exp Med 179:413
Dobrescu D, Ursea B, Pope M, Asch AS, Posnett DN (1995) Enhanced HIV-1 replication in Vβ12 T cells due to human cytomegalovirus in monocytes: evidence for a putative herpesvirus superantigen. Cell 82:753
Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M (1986) The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233:215
Alter HJ, Eichberg JW, Masur H, Saxinger WC, Gallo R, Macher AM, Lane HC, Fauci AS (1984) Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. Science 226:549
Fultz, PN, McClure HM, Swenson RB, McGrath CR, Brodie A, Getchell JP, Jensen FC, Anderson DC, Broderson JR, Francis DP (1986) Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome. J Virol 58:116
Desrosiers RC (1988) Simian immunodeficiency viruses. Annu Rev Microbiol 42:607
Daniel MD, Letvin NL, King NW, Kannagi M, Sehgal PK, Hunt RD, Kanki PJ, Essex M, Desrosiers RC (1985) Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 228:1201
Meyers G, Rabson AB, Berzofsky JA, Smith FT and Wong-Staals, (eds) (1990). Human retroviruses and AIDS: acompilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory, New Mexico
Desrosiers RC (1990) The simian immunodeficiency viruses. Annu Rev Immunol 8:557
Beneviste RE, Morton WR, Clark EA, Tsai CC, Ochs HD, Ward JM, Kuller L, Knott WB, Hill RW, Gale MJ, Thouless ME (1988) Inoculation of baboons and macaques with simian immunodeficiency virus/Mne, a primate lentivirus closely related to human immunodeficiency virus type 2. J Virol 62:2091
Letvin NL, Daniel MD, Sehgal PK, Desrosiers RC, Hunt RD, Waldron LM, Mackey JJ, Schmidt DK, Chalifoux LV, King NW (1985) Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 230:71
Murphey-Corb M, Martin LN, Rangan SRS, Baskin GB, Gormus BJ, Wolf RH, Andes WA, West M, Montelaro RC (1986) Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys. Nature 321:435
Chen ZW, Kou Z-C, Shen L, Reimann KA, Letvin NM (1993) Conserved T-cell receptor repertoire in simian immunodeficiency virus-infected Rhesus monkeys. J Immunol 151:2177
Fultz PN, McClure HM, Anderson DC, Switzer WM (1989) Identification and biological characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM). AIDS Res Hum Retroviruses 5:397
Lewis MG, Zack PM, Elkins WR, Jahrling PB (1992) Infection of Rhesus and Cynomolgus macaclues with a rapidly fatal SIV (SIV SMM/PBj) isolate from sooty mangabeys. AIDS Res Hum Retrovir 8:1631
Novembre FJ, Johnson PR, Lewis MG, Anderson DC, Klumpp S, McClure HM, Hirsch VM (1993) Multiple viral determinants contribute to pathogenicity of the acutely lethal simian immunodeficiency virus SIVsmmPBj variant. J Virol 67:2466
Dewhurst S, Embretson JE, Anderson DC, Mullins JI, Fultz PN (1990) Sequence analysis and acute pathogenicity of molecularly cloned SIVsmm-PBj14. Nature 345:636
Du Z, Lang SM, Sasseville VG, Lackner AA, Ilyinskii PO, Daniel MD, Jung JU, Desrosiers RC (1995) Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 82:665
Legrand E, Daculsi R, Duplan JF (1981) Characteristics of the cell populations involved in extra-thymic lymphosarcoma induced in C57BL/6 mice by RadLV-Rs. Leuk Res 5:223
Aziz DC, Hanna Z, Jolicoeur P (1989) Severe immunodeficiency disease induced by a defective murine leukaemia virus. Nature 338:505
Hartley JW, Fredrickson TN, Yetter RA, Makino M, Morse HC III (1989) Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains. J Virol 63:1223
Morse HC III, Chattopadhyay SK, Makino M, Fredrickson TN, Hügin AW, Hartley JW (1992) Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS 6:607
Kubo Y, Nakagawa Y, Kakimi K, Matsui H, Iwashiro M, Kuribayashi K, Masuda T, Hiai H, Hirama T, Yanagawa SI, Ishimoto A (1992) Presence of transplantable T-lymphoid cells in C57BL/6 mice infected with murine AIDS virus. J Virol 66:5691
Huang M, Simard C, Kay DG, Jolicoeur P (1991) The majority of cells infected with the defective murine AIDS virus belong to the B cell lineage. J Virol 65:6562
Simard C, Jolicoeur P (1991) The effect of anti-neoplastic drugs on murine acquired immunodeficiency syndrome. Science 251:305
Huang M, Hanna Z, Jolicoeur P (1995) Mutational analysis of the murine AIDS-defective viral genome reveals a high reversion rate in vivo and a requirement for an intact pr60gag protein for efficient induction of disease. J Virol 69:60
Hügin AW, Vacchio MS, Morse III HC (1991) A virus-encoded superantigen in a retrovirus-induced immunodeficiency syndrome of mice. Science 252:424
Selvey LA, Morse HC III, Granger LG, Hodes RJ (1993) Preferential expansion and activation of Vβ5+ CD4+ T cells in murine acquired immunodeficiency syndrome. J Immunol 515:1712
Huang M, Takac M, Kozac CA, Jolicoeur P (1995) The murine AIDS defective provirus acts as an insertional mutagen in its infected target B cells. J Virol 69:4069
Moskophidis D, Lechner F, Pircher H, Zinkernagel RM (1993) Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ciurli, C., Sékaly, RP. & Soudeyns, H. Study of the T cell receptor repertoire in viral immunodeficiency disease. Springer Semin Immunopathol 17, 319–332 (1996). https://doi.org/10.1007/BF01795132
Issue Date:
DOI: https://doi.org/10.1007/BF01795132